PHOTRONICS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PHOTRONICS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Oct 31, 2018 | $144.66M | Dec 21, 2018 |
| FY2018 | Jul 29, 2018 | $136.39M | Dec 21, 2018 |
| FY2018 | Apr 29, 2018 | $130.78M | Dec 21, 2018 |
| FY2018 | Jan 28, 2018 | $123.45M | Dec 21, 2018 |
| FY2018 | Oct 29, 2017 | $120.97M | Dec 21, 2018 |
| FY2018 | Jul 30, 2017 | $111.58M | Dec 21, 2018 |
| FY2018 | Apr 30, 2017 | $108.30M | Dec 21, 2018 |
| FY2018 | Jan 29, 2017 | $109.83M | Dec 21, 2018 |
| FY2018 | Oct 30, 2016 | $483.46M | Dec 21, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $849.29M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $866.95M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $892.08M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $824.55M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $663.76M | Dec 26, 2023 |
| FY2020 | Oct 31, 2020 | $149.29M | Jan 15, 2021 |
| FY2020 | Aug 2, 2020 | $157.90M | Jan 15, 2021 |
| FY2020 | May 3, 2020 | $142.77M | Jan 15, 2021 |
| FY2020 | Feb 2, 2020 | $159.74M | Jan 15, 2021 |
| FY2020 | Oct 31, 2019 | $156.26M | Jan 15, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $299.83M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $315.95M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $336.16M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $294.21M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $167.04M | Dec 26, 2023 |
| FY2020 | Oct 31, 2020 | $31.89M | Jan 15, 2021 |
| FY2020 | Aug 2, 2020 | $37.73M | Jan 15, 2021 |
| FY2020 | May 3, 2020 | $30.43M | Jan 15, 2021 |
| FY2020 | Feb 2, 2020 | $34.60M | Jan 15, 2021 |
| FY2020 | Oct 31, 2019 | $38.16M | Jan 15, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $136.41M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $130.69M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $125.49M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $118.79M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $55.45M | Dec 26, 2023 |
| FY2020 | Oct 31, 2020 | $6.46M | Jan 15, 2021 |
| FY2020 | Aug 2, 2020 | $10.78M | Jan 15, 2021 |
| FY2020 | May 3, 2020 | $6.28M | Jan 15, 2021 |
| FY2020 | Feb 2, 2020 | $10.30M | Jan 15, 2021 |
| FY2020 | Oct 31, 2019 | $9.70M | Jan 15, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $208.16M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $221.52M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $253.05M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $211.87M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $94.55M | Dec 26, 2023 |
| FY2022 | Oct 31, 2020 | $63.93M | Dec 23, 2022 |
| FY2021 | Oct 31, 2019 | $52.12M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $65.63M | Jan 15, 2021 |
| FY2019 | Oct 29, 2017 | $31.87M | Dec 23, 2019 |
| FY2018 | Oct 30, 2016 | $52.48M | Dec 21, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $15.80M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $16.58M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $13.65M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $18.34M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $18.49M | Dec 26, 2023 |
| FY2022 | Oct 31, 2020 | $17.14M | Dec 23, 2022 |
| FY2021 | Oct 31, 2019 | $16.39M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $14.48M | Jan 15, 2021 |
| FY2019 | Oct 29, 2017 | $15.86M | Dec 23, 2019 |
| FY2018 | Oct 30, 2016 | $21.65M | Dec 21, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $75.63M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $77.76M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $69.46M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $63.99M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $57.53M | Dec 26, 2023 |
| FY2022 | Oct 31, 2020 | $53.58M | Dec 23, 2022 |
| FY2021 | Oct 31, 2019 | $52.33M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $51.40M | Jan 15, 2021 |
| FY2019 | Oct 29, 2017 | $43.59M | Dec 23, 2019 |
| FY2018 | Oct 30, 2016 | $44.58M | Dec 21, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $247.80M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $261.44M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $302.18M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $275.19M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $150.77M | Dec 26, 2023 |
| FY2022 | Oct 31, 2020 | $143.05M | Dec 23, 2022 |
| FY2021 | Oct 31, 2019 | $68.39M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $130.57M | Jan 15, 2021 |
| FY2019 | Oct 29, 2017 | $96.83M | Dec 23, 2019 |
| FY2018 | Oct 30, 2016 | $122.14M | Dec 21, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $188.14M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $130.94M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $131.30M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $112.34M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $109.10M | Dec 26, 2023 |
| FY2022 | Oct 31, 2020 | $70.82M | Dec 23, 2022 |
| FY2021 | Oct 31, 2019 | $178.38M | Dec 17, 2021 |
| FY2020 | Oct 31, 2018 | $92.59M | Jan 15, 2021 |
| FY2019 | Oct 29, 2017 | $91.97M | Dec 23, 2019 |
| FY2018 | Oct 30, 2016 | $50.15M | Dec 21, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $1.80B | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $1.71B | Dec 17, 2025 |
| FY2024 | Oct 31, 2023 | $1.53B | Dec 19, 2024 |
| FY2023 | Oct 31, 2022 | $1.32B | Dec 26, 2023 |
| FY2022 | Oct 31, 2021 | $1.29B | Dec 23, 2022 |
| FY2021 | Oct 31, 2020 | $1.19B | Dec 17, 2021 |
| FY2020 | Oct 31, 2019 | $1.12B | Jan 15, 2021 |
| FY2019 | Oct 31, 2018 | $1.11B | Dec 23, 2019 |
| FY2018 | Oct 29, 2017 | $1.02B | Dec 21, 2018 |
| FY2017 | Oct 30, 2016 | $987.99M | Dec 20, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $207.23M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $231.30M | Dec 17, 2025 |
| FY2024 | Oct 31, 2023 | $250.61M | Dec 19, 2024 |
| FY2023 | Oct 31, 2022 | $253.74M | Dec 26, 2023 |
| FY2022 | Oct 31, 2021 | $293.64M | Dec 23, 2022 |
| FY2021 | Oct 31, 2020 | $225.92M | Dec 17, 2021 |
| FY2020 | Oct 31, 2019 | $207.57M | Jan 15, 2021 |
| FY2019 | Oct 31, 2018 | $205.44M | Dec 23, 2019 |
| FY2018 | Oct 29, 2017 | $155.50M | Dec 21, 2018 |
| FY2017 | Oct 30, 2016 | $162.51M | Dec 20, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $1.17B | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $1.12B | Dec 17, 2025 |
| FY2024 | Oct 31, 2023 | $975.01M | Dec 19, 2024 |
| FY2023 | Oct 31, 2022 | $831.53M | Dec 26, 2023 |
| FY2022 | Oct 31, 2021 | $823.69M | Dec 23, 2022 |
| FY2021 | Oct 31, 2020 | $804.96M | Dec 17, 2021 |
| FY2020 | Oct 31, 2019 | $769.89M | Jan 15, 2021 |
| FY2019 | Oct 31, 2018 | $759.67M | Dec 23, 2019 |
| FY2018 | Oct 29, 2017 | $744.56M | Dec 21, 2018 |
| FY2017 | Oct 30, 2016 | $710.36M | Dec 20, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $772.20M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $691.81M | Dec 17, 2025 |
| FY2024 | Oct 31, 2023 | $561.12M | Dec 19, 2024 |
| FY2023 | Oct 31, 2022 | $435.63M | Dec 26, 2023 |
| FY2022 | Oct 31, 2021 | $317.85M | Dec 23, 2022 |
| FY2021 | Oct 31, 2020 | $279.04M | Dec 17, 2021 |
| FY2020 | Oct 31, 2019 | $253.92M | Jan 15, 2021 |
| FY2019 | Oct 31, 2018 | $231.45M | Dec 23, 2019 |
| FY2018 | Oct 29, 2017 | $189.39M | Dec 21, 2018 |
| FY2017 | Oct 30, 2016 | $176.26M | Dec 20, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $492.26M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | $598.49M | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | $499.29M | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | $319.68M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $276.67M | Dec 26, 2023 |
| FY2022 | Oct 31, 2020 | $278.67M | Dec 23, 2022 |
| FY2021 | Oct 31, 2019 | $206.53M | Dec 17, 2021 |
| FY2019 | Oct 31, 2018 | $329.28M | Dec 23, 2019 |
| FY2018 | Oct 29, 2017 | $308.02M | Dec 21, 2018 |
| FY2018 | Oct 30, 2016 | $314.07M | Dec 21, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Oct 31, 2020 | $63.95M | Jan 15, 2021 |
| FY2020 | Oct 31, 2019 | $44.03M | Jan 15, 2021 |
| FY2019 | Oct 31, 2018 | $57.45M | Dec 23, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 2 | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | 2 | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | 2 | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | 1 | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | 0 | Dec 26, 2023 |
| FY2020 | Oct 31, 2020 | 0 | Jan 15, 2021 |
| FY2020 | Aug 2, 2020 | 0 | Jan 15, 2021 |
| FY2020 | May 3, 2020 | 0 | Jan 15, 2021 |
| FY2020 | Feb 2, 2020 | 0 | Jan 15, 2021 |
| FY2020 | Oct 31, 2019 | 0 | Jan 15, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 2 | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | 2 | Dec 17, 2025 |
| FY2025 | Oct 31, 2023 | 2 | Dec 17, 2025 |
| FY2024 | Oct 31, 2022 | 1 | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | 0 | Dec 26, 2023 |
| FY2020 | Oct 31, 2020 | 0 | Jan 15, 2021 |
| FY2020 | Aug 2, 2020 | 0 | Jan 15, 2021 |
| FY2020 | May 3, 2020 | 0 | Jan 15, 2021 |
| FY2020 | Feb 2, 2020 | 0 | Jan 15, 2021 |
| FY2020 | Oct 31, 2019 | 0 | Jan 15, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 57.63M | Dec 17, 2025 |
| FY2025 | Oct 31, 2024 | 61.95M | Dec 17, 2025 |
| FY2024 | Oct 31, 2023 | 61.31M | Dec 19, 2024 |
| FY2023 | Oct 31, 2022 | 60.79M | Dec 26, 2023 |
| FY2022 | Oct 31, 2021 | 60.02M | Dec 23, 2022 |
| FY2021 | Oct 31, 2020 | 63.14M | Dec 17, 2021 |
| FY2020 | Oct 31, 2019 | 65.60M | Jan 15, 2021 |
| FY2019 | Oct 31, 2018 | 67.14M | Dec 23, 2019 |
| FY2018 | Oct 29, 2017 | 68.67M | Dec 21, 2018 |
| FY2017 | Oct 30, 2016 | 68.08M | Dec 20, 2017 |